SAN DIEGO, Aug. 3, 2015 (GLOBE NEWSWIRE) -- San Diego's HempMeds™ is proud to announce its support for the cannabis industry as a presenting sponsor at the 1st annual San Diego Cannabis Professionals Cup. There, Medical Marijuana, Inc.'s HempMeds™ will showcase their cannabidiol (CBD) hemp oil portfolio brands such as Dixie Botanicals®, Real Scientific Hemp Oil™ (RSHO™) as featured in the Wall Street Journal, and more.
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=34857
"The reality is that toddlers, seniors, Veterans, professional athletes – even pets – are today's cannabis consumers," states Andrew Hard, Spokesperson for HempMeds™. "HempMeds is proud to support the rapidly growing cannabis industry at the San Diego Cannabis Professionals Cup. The non-psychoactive hemp CBD oil products that HempMeds represents and distributes are available in all 50 states without a medical recommendation. These innovative products offer 'low THC cannabis' options for consumers of all ages who are seeking CBD oil from hemp."
Concussions in "collision sports" – a term coined by NFL star Marvin Washington – has captured headline news. Concussions were the reason that former NFL star, Chris Borland, chose an early retirement. This is a major topic of conversation at the San Diego Cannabis Professionals Cup. One professional athlete slated to speak about cannabis use at the San Diego Cannabis Professionals Cup is former NFL star, Kyle Turley, who is cited by the U-T San Diego as officially being diagnosed with two concussions – but feels that more went undetected.
According to an article by ESPN, Turley appeared in 109 games with the New Orleans Saints, St. Louis Rams and Kansas City Chiefs and was a first-team All-Pro selection in 2000. Successive concussions are related to a condition called chronic traumatic encephalopathy (CTE); this is the same condition that Pro Football and San Diego Chargers Hall of Fame inductee, Junior Seau, was diagnosed with after his suicide in 2012. The article by ESPN states that, as Seau did, Turley has also agreed to have his brain donated to medical research after his death.
Hard continues, "Conversations about cannabis use for post-traumatic stress disorder (PTSD), traumatic brain injury (TBI), chronic traumatic encephalopathy (CTE) and concussions are more prevalent in headline news and documentaries. We encourage the public to become more aware of hemp and cannabis history in the U.S. and around the world. This is an ancient botanical that is rapidly making a comeback on the global landscape. This single plant species has the potential to positively impact the global economy with its return to the marketplace."
The San Diego Cannabis Professionals Cup features live entertainment and takes place on Saturday, August 8, from 10:00 a.m. to 9:00 p.m. at 2863 Historic Decatur Rd. San Diego, CA 92106 (details are at http://www.sandiegocup.com/). Admission is $35 per person or $100 for judging passes; the event is open to valid Proposition 215 patients with ID and California driver's license ages 18 and up.
HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company's exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana, Inc.
Our mission is to be the premier hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at: www.MedicalMarijuanaInc.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of hemp-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.
CONTACT: For further information, please contact: Public Relations contact: Andrew Hard Spokesperson CMW Media P. 858-380-5478 email@example.com Corporate contact: Medical Marijuana, Inc. Toll Free: 888-OTC-MJNA (888-682-6562) www.medicalmarijuanainc.com www.facebook.com/mjnainc Investor Relations: GH Investment Advisors 550 West "C" Street, Ste. 2040 San Diego, CA 92101 Nick Massalas Office: (858) 264-6500 Toll Free: (877) 964-6463 firstname.lastname@example.org
Source:Medical Marijuana Inc